The study analyzed three different groups containing six rats. One group was treated with SVF the day of the TBI, another group treated with SVF three days after the TBI, and the other group treated with lactated ringers (a saline composed of water and electrolytes) the day of the TBI. An Invitrogen Countess was used to estimate the total cells delivered to the injury, meanwhile fluorescence-activated cell sorting was used to differentiate the cell types.
Both tracking and data collection devices found SVF was visible in the damaged brain, proving that SVF concentrates and targets the specific site of the injury. The researcher, Sean Berman, also tested the rats’ motor skills. Results showed that there were significant improvements after only 14 days of the injury. The “same day” SVF group and 3 day post-TBI SVF group were performing 30% to 55% better than the saline group.